A federal lawsuit questions the ownership of Trump's tweets, which could have significant implications for the presidency and intellectual property. This does not seem to have a direct impact on the Argentine market, but could influence investors' perception of public information management.
A federal lawsuit currently in US courts seeks to determine the legitimate owner of the tweets published by former President Donald Trump during his tenure. The company Truth API argues that Trump cannot sell advance access to his presidential publications for $100,000, as these belong to the public domain.
The federal lawsuit raises a fundamental question about intellectual property in the context of the presidency. Trump's tweets, although personal, were published during his tenure and are therefore considered part of the public record. The company Truth API asserts that access to these tweets should not be restricted or sold, as they belong to the nation's cultural and political heritage.
The importance of this lawsuit lies in defining the boundaries between personal and public property in the context of the presidency. If it is resolved that Trump's tweets belong to the public domain, they could have significant implications for how presidential records are managed and accessed in the future.
Intellectual property is a delicate topic in the context of the presidency, as official records and publications can contain sensitive and political information. The resolution of this lawsuit could set a precedent for future administrations and determine how copyrights and intellectual property are handled in the presidential context.
In the next 30 days, it is expected that the court will make a decision on the lawsuit, which could have a significant impact on how intellectual property is perceived in the presidency and public information management.
El Banco Central permite que las financieras usen hasta el 15 % de sus depósitos en dólares para otorgar préstamos a empresas, una medida que busca reactivar la inversión productiva.
La acción de Moderna subió 95 % después de que su vacuna de ARN mensajero contra el cáncer, desarrollada con Merck, obtuviera el primer resultado positivo en una fase 3.
El pronóstico más audaz de Wall Street sitúa al S&P 500 en 9.000 para fin de 2027, un 17 % por encima del nivel actual.
